These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7137396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
    Piscitelli SC, Frazier JA, McKenna K, Albus KE, Grothe DR, Gordon CT, Rapoport JL.
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
    [Abstract] [Full Text] [Related]

  • 6. Haloperidol plasma levels and clinical response: a therapeutic window relationship.
    Van Putten T, Marder SR, Mintz J, Poland RE.
    Am J Psychiatry; 1992 Apr; 149(4):500-5. PubMed ID: 1554036
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of repeated drug holidays on serum haloperidol concentrations, psychiatric symptoms, and movement disorders in schizophrenic patients.
    Newton JE, Cannon DJ, Couch L, Fody EP, McMillan DE, Metzer WS, Paige SR, Reid GM, Summers BN.
    J Clin Psychiatry; 1989 Apr; 50(4):132-5. PubMed ID: 2925601
    [Abstract] [Full Text] [Related]

  • 9. An open trial of buspirone added to neuroleptics in schizophrenic patients.
    Goff DC, Midha KK, Brotman AW, McCormick S, Waites M, Amico ET.
    J Clin Psychopharmacol; 1991 Jun; 11(3):193-7. PubMed ID: 2066458
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The interpretation of plasma haloperidol concentrations.
    Kirch DG, Bigelow LB, Wyatt RJ.
    Arch Gen Psychiatry; 1985 Aug; 42(8):838-40. PubMed ID: 4015329
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of haloperidol plasma concentrations between twice-a-day and once-a-day dosing in Chinese schizophrenic patients.
    Lin SK, Chen CH, Chang WH.
    J Formos Med Assoc; 1993 Sep; 92(9):832-4. PubMed ID: 7904867
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidol.
    Chang WH, Shieh YS, Liu HC, Jann MW, Chien CP.
    Eur Neuropsychopharmacol; 1994 Jun; 4(2):119-26. PubMed ID: 7919941
    [Abstract] [Full Text] [Related]

  • 20. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients.
    Lin KM, Poland RE, Nuccio I, Matsuda K, Hathuc N, Su TP, Fu P.
    Am J Psychiatry; 1989 Oct; 146(10):1307-11. PubMed ID: 2782476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.